SEC Form D filing

Amlogenyx Inc., 2026-07-09

An SEC Form D private-offering notice from Novato, CA, a $20,000,000 filer-stated offering target in Biotech. Filed 2026-07-09. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Amlogenyx Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing AAV gene therapies to reduce amyloid accumulation in Alzheimer's disease

Filed 2026-07-09Filed to raise $20,000,000First money in 2026-07-01Raised so far $10,000,000HQ (as filed) Novato, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified amlogenyx.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source